S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

FFWM First Foundation Inc

7.40

0.00 (0.00%)

Mar 03 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

0001558370-24-011643.txt

First Foundation (NASDAQ:FFWM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more First Foundation Charts.

First Foundation (NASDAQ:FFWM)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more First Foundation Charts.

First Foundation Inc News

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 10 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 9 September 2024 (6 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Thursday 22 August 2024 (6 months ago) • Edgar (US Regulatory)

Form PRER14A - Preliminary Proxy Soliciting materials
Friday 16 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (7 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Monday 29 July 2024 (7 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 2 July 2024 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 2 July 2024 (8 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 5 June 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 29 May 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Thursday 9 May 2024 (10 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (10 months ago) • Edgar (US Regulatory)

More First Foundation Inc News Articles

Valiant Eagle (PK)

Anavex Life Sciences

Asia Broadband (PK)

Rennova Health (CE)

Elite Pharmaceuticals (QB)

Bioelectronics (PK)

Global Developments (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions